$RZLT
Rezolute, Inc. Stock $rzlt

$rzlt Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000114420415031206 Filed on May 15, 2015

Income Statement

Concept	2015 Q2	2015 Q1	2014 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.760M	$1.380M	$1.540M
YoY Change	14.29%	-13.21%	52.48%
% of Gross Profit
Research & Development	$1.280M	$1.291M	$30.00K
YoY Change	4166.67%	57370.84%
% of Gross Profit
Depreciation & Amortization	$50.00K	$33.11K	$10.00K
YoY Change	400.0%
% of Gross Profit
Operating Expenses	$3.090M	$2.300M	$2.230M
YoY Change	38.57%	44.18%	120.79%
Operating Profit		-$2.300M
YoY Change		44.18%
Interest Expense	$50.00K	$2.086K	$220.0K
YoY Change	-77.27%	-99.94%	-1200.0%
% of Operating Profit
Other Income/Expense, Net		-$872.4K
YoY Change		-75.01%
Pretax Income	-$3.040M	-$3.170M	-$2.010M
YoY Change	51.24%	-37.72%	95.15%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$3.040M	-$3.173M	-$2.010M
YoY Change	51.24%	-37.63%	95.15%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$6.204M	-$7.044M	-$5.743M
COMMON SHARES
Basic Shares Outstanding	24.34M shares	22.00M shares	17.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q2	2015 Q1	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.280M	$8.220M	$5.930M
YoY Change	-10.96%	45.74%
Cash & Equivalents	$5.280M	$8.220M	$5.930M
Short-Term Investments
Other Short-Term Assets	$320.3K	$630.0K	$83.43K
YoY Change	283.93%	425.0%	-12.62%
Inventory	$67.22K	$92.43K	$289.6K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$6.116M	$8.940M	$6.308M
YoY Change	-3.03%	49.5%	673.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.525M	$2.303M	$337.9K
YoY Change	1239.0%	722.53%	22.56%
Goodwill
YoY Change
Intangibles		$60.73K	$9.161K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$560.0K	$750.0K	$750.0K
YoY Change	-25.33%
Total Long-Term Assets	$5.147M	$3.120M	$1.097M
YoY Change	369.13%	975.86%	280.38%
TOTAL ASSETS
Total Short-Term Assets	$6.116M	$8.940M	$6.308M
Total Long-Term Assets	$5.147M	$3.120M	$1.097M
Total Assets	$11.26M	$12.06M	$7.405M
YoY Change	52.11%	92.34%	570.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.410M	$1.330M	$460.3K
YoY Change	206.31%	-24.86%	144.4%
Accrued Expenses	$10.00K	$10.00K	$10.00K
YoY Change	0.0%	-90.0%	-97.37%
Deferred Revenue
YoY Change
Short-Term Debt	$60.00K	$60.00K	$60.00K
YoY Change	0.0%	-93.26%	-98.39%
Long-Term Debt Due	$90.00K	$90.00K
YoY Change
Total Short-Term Liabilities	$1.710M	$1.798M	$964.0K
YoY Change	77.38%	-37.17%	-81.69%
LONG-TERM LIABILITIES
Long-Term Debt	$20.00K	$50.00K	$0.00
YoY Change
Other Long-Term Liabilities	$480.0K	$506.5K	$33.88K
YoY Change	1316.72%
Total Long-Term Liabilities	$503.6K	$553.4K	$33.88K
YoY Change	1386.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.710M	$1.798M	$964.0K
Total Long-Term Liabilities	$503.6K	$553.4K	$33.88K
Total Liabilities	$2.209M	$2.352M	$997.9K
YoY Change	121.4%	-17.76%	-81.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.11M	-$26.07M	-$17.75M
YoY Change	64.02%
Common Stock	$24.34K	$23.54K	$18.09K
YoY Change	34.54%	61.02%	171.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.054M	$9.704M	$6.407M
YoY Change
Total Liabilities & Shareholders Equity	$11.26M	$12.06M	$7.405M
YoY Change	52.11%	92.28%	570.73%

Cashflow Statement

Concept	2015 Q2	2015 Q1	2014 Q2
OPERATING ACTIVITIES
Net Income	-$3.040M	-$3.173M	-$2.010M
YoY Change	51.24%	-37.63%	95.15%
Depreciation, Depletion And Amortization	$50.00K	$33.11K	$10.00K
YoY Change	400.0%
Cash From Operating Activities	-$1.960M	-$1.910M	-$2.100M
YoY Change	-6.67%	169.01%	813.04%
INVESTING ACTIVITIES
Capital Expenditures	-$2.230M	-$610.0K	-$70.00K
YoY Change	3085.71%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$450.0K	-$750.0K
YoY Change	-100.0%
Cash From Investing Activities	-$2.230M	-$1.060M	-$820.0K
YoY Change	171.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.250M	2.610M	3.210M
YoY Change	-61.06%	-49.9%	-2106.25%
NET CHANGE
Cash From Operating Activities	-1.960M	-1.910M	-2.100M
Cash From Investing Activities	-2.230M	-1.060M	-820.0K
Cash From Financing Activities	1.250M	2.610M	3.210M
Net Change In Cash	-2.940M	-360.0K	290.0K
YoY Change	-1113.79%	-108.0%	-174.36%
FREE CASH FLOW
Cash From Operating Activities	-$1.960M	-$1.910M	-$2.100M
Capital Expenditures	-$2.230M	-$610.0K	-$70.00K
Free Cash Flow	$270.0K	-$1.300M	-$2.030M
YoY Change	-113.3%	83.1%	782.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	96015	USD
CY2014Q2	us-gaap	Assets Assets	7404652	USD
CY2015Q1	us-gaap	Liabilities Liabilities	2351926	USD
CY2014Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	460311	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2303080	USD
CY2014Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	USD
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	92912	USD
CY2014Q2	us-gaap	Liabilities Liabilities	997921	USD
CY2014Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of Estimates</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">  </font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the financial statements and the accompanying notes. Such estimates and assumptions impact, among others, the following: estimated useful lives and potential impairment of intangible assets, the fair value of share-based payments and warrants, estimates of the probability and potential magnitude of contingent liabilities and the valuation allowance for deferred tax assets due to continuing and expected future operating losses.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q2	us-gaap	Cash Cash	5934534	USD
CY2015Q1	us-gaap	Inventory Net InventoryNet	92425	USD
CY2014Q2	us-gaap	Inventory Net InventoryNet	289600	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	337932	USD
CY2015Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	60729	USD
CY2014Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9161	USD
CY2015Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	750000	USD
CY2014Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	750000	USD
CY2014Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1097093	USD
CY2015Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1325754	USD
CY2014Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	397055	USD
CY2014Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	0	USD
CY2015Q1	us-gaap	Interest Payable Current InterestPayableCurrent	12579	USD
CY2015Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	211221	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1798481	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	506499	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33881	USD
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	46946	USD
CY2014Q2	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	553445	USD
CY2014Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	33881	USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	6406731	USD
CY2015Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	23536	USD
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	18092	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35750392	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	24135563	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26069824	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17746924	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	9704104	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12056030	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7404652	USD
CY2013Q1	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	5880667	shares
CY2013Q1	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.882	pure
	antb	Fair Value Of Financial Instruments Earnings FairValueOfFinancialInstrumentsEarnings	717733	USD
	antb	Warrants Recorded As Derivative Liability WarrantsRecordedAsDerivativeLiability	-1675498	USD
CY2015Q1	us-gaap	Financial Instruments Owned At Fair Value FinancialInstrumentsOwnedAtFairValue	-211221	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1131741	USD
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23012	USD
CY2015Q1	antb	Working Capital Deficit WorkingCapitalDeficit	7143740	USD
CY2013Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	400000	USD
CY2013Q1	antb	Business Acquisition Purchases Price Allocation Assets Acquired BusinessAcquisitionPurchasesPriceAllocationAssetsAcquired	100000	USD
CY2014Q4	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	55000	USD
CY2014Q1	antb	Consulting Expenses ConsultingExpenses	172530	USD
CY2015Q1	antb	Consulting Expenses ConsultingExpenses	33000	USD
	antb	Consulting Expenses ConsultingExpenses	334204	USD
	antb	Consulting Expenses ConsultingExpenses	99000	USD
CY2015Q1	antb	Related Party Expenses RelatedPartyExpenses	0	USD
CY2014Q2	antb	Related Party Expenses RelatedPartyExpenses	397055	USD
CY2014Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18091792	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18091792	shares
CY2015Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	60000	USD
CY2014Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	60000	USD
CY2015Q1	antb	Third Party Capital Investment ThirdPartyCapitalInvestment	2500000	USD
CY2011Q2	antb	Percentage Of Common Share Price Of Financing PercentageOfCommonSharePriceOfFinancing	0.65	pure
	antb	Percentage Of Common Share Price Of Financing PercentageOfCommonSharePriceOfFinancing	0.65	pure
CY2011Q2	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	2000000	USD
CY2012Q3	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	2000000	USD
CY2012Q4	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	1000000	USD
CY2011Q2	antb	Qualified Offering Common Stock QualifiedOfferingCommonStock	5000000	USD
CY2011Q2	antb	Maximum Conversion Pre Money Valuation MaximumConversionPreMoneyValuation	20000000	USD
CY2011Q2	antb	Percentage Of Exercise Per Share On Price Per Common Share PercentageOfExercisePerShareOnPricePerCommonShare	1.35	pure
CY2012Q3	antb	Description Of Convertible Notes DescriptionOfConvertibleNotes	On the maturity date of the convertible notes, or the closing of a Sale of the Company, whichever occurs first, the lenders are permitted an elective conversion option to convert the outstanding principal and interest on the convertible notes at the lower of 65% of the price per share of common stock in the Qualified Financing or 65% of the common stock price using a pre-money valuation of the Company of $20 million.
CY2012Q4	antb	Description Of Convertible Notes DescriptionOfConvertibleNotes	On the date of a Qualified Financing, the lenders are permitted an elective conversion option to convert the outstanding principal and interest at the lower of 50% of the price per share of common stock in the Qualified Financing or $4.50 per share.
CY2012Q3	antb	Percentage Of Price Per Common Share On Warrant To Purchase Two Shares Of Common Stock PercentageOfPricePerCommonShareOnWarrantToPurchaseTwoSharesOfCommonStock	1.35	pure
CY2015Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2011Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2012Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2012Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.08	pure
CY2013	antb	Additional Warrants Issued AdditionalWarrantsIssued	562352	shares
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	1361355	USD
CY2014Q1	us-gaap	Professional Fees ProfessionalFees	228308	USD
CY2015Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	105000	shares
	antb	Advertising Expenses For Common Stock AdvertisingExpensesForCommonStock	296669	USD
CY2014Q1	antb	Services Agreement Expenses ServicesAgreementExpenses	500000	USD
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	138888	shares
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	12397853	USD
CY2014	antb	Fair Value Of Warrants FairValueOfWarrants	35595	USD
	antb	Fair Value Of Warrants FairValueOfWarrants	38412	USD
CY2015Q1	antb	Class Of Warrant Exercisable Warrants Or Rights ClassOfWarrantExercisableWarrantsOrRights	41424	shares
CY2015Q1	antb	Warrants To Purchase Common Stock Value WarrantsToPurchaseCommonStockValue	80677	USD
CY2014Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	690187	USD
CY2014Q2	antb	Maximum Convertible Notes Payable Issuance MaximumConvertibleNotesPayableIssuance	1000000	USD
CY2014Q1	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	0	USD
CY2015Q1	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	166472	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	0	USD
	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	425891	USD
CY2014Q1	us-gaap	Manufacturing Costs ManufacturingCosts	2246	USD
CY2015Q1	us-gaap	Manufacturing Costs ManufacturingCosts	296385	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	2246	USD
	us-gaap	Manufacturing Costs ManufacturingCosts	871308	USD
CY2014Q1	antb	Facilites And Other Costs FacilitesAndOtherCosts	0	USD
CY2015Q1	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	628252	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	0	USD
	antb	Compensation And Benefits For Research And Development CompensationAndBenefitsForResearchAndDevelopment	1306806	USD
CY2014Q1	antb	Consultants And Outside Costs ConsultantsAndOutsideCosts	0	USD
CY2015Q1	antb	Facilites And Other Costs FacilitesAndOtherCosts	199686	USD
	antb	Facilites And Other Costs FacilitesAndOtherCosts	0	USD
	antb	Facilites And Other Costs FacilitesAndOtherCosts	365511	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2246	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1290795	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2246	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2969516	USD
CY2014Q1	antb	Consulting Fees ConsultingFees	221263	USD
CY2015Q1	antb	Consulting Fees ConsultingFees	33000	USD
	antb	Consulting Fees ConsultingFees	383288	USD
	antb	Consulting Fees ConsultingFees	349633	USD
CY2014Q1	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	591023	USD
CY2015Q1	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	780500	USD
	antb	Compensation And Benefits For General And Administrative CompensationAndBenefitsForGeneralAndAdministrative	2828032	USD
CY2015Q1	us-gaap	Professional Fees ProfessionalFees	72270	USD
	us-gaap	Professional Fees ProfessionalFees	470926	USD
	us-gaap	Professional Fees ProfessionalFees	362339	USD
CY2014Q1	antb	Investor Relations InvestorRelations	0	USD
CY2015Q1	antb	Investor Relations InvestorRelations	36602	USD
	antb	Investor Relations InvestorRelations	0	USD
	antb	Investor Relations InvestorRelations	468047	USD
CY2014Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	552539	USD
CY2015Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	87033	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	728505	USD
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	626777	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1593133	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1009405	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2944074	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4634828	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	1595379	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	2300200	USD
	us-gaap	Operating Expenses OperatingExpenses	2946320	USD
	us-gaap	Operating Expenses OperatingExpenses	7604344	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1595379	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2300200	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2946320	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7604344	USD
CY2014Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3667	USD
CY2015Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1093	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	10500	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4062	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	3441448	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	2086	USD
	us-gaap	Interest Expense InterestExpense	4229612	USD
	us-gaap	Interest Expense InterestExpense	4885	USD
CY2014Q1	us-gaap	Other General Expense OtherGeneralExpense	53970	USD
CY2015Q1	us-gaap	Other General Expense OtherGeneralExpense	871447	USD
	us-gaap	Other General Expense OtherGeneralExpense	559791	USD
	us-gaap	Other General Expense OtherGeneralExpense	717733	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3491751	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-872440	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4778903	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-718556	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-5087130	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-3172640	USD
	us-gaap	Net Income Loss NetIncomeLoss	-7725223	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8322900	USD
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.76
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.16
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6671537	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	22542821	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6669896	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19840425	shares
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	88552	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	359468	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	370252	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	381360	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	392855	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	335747	USD
CY2015Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1928234	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	24222	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	96890	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	24223	USD
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	145335	USD
CY2014Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	28939	USD
CY2014Q2	antb	Payments Of Monthly Lease Adjusted Annually Percentage PaymentsOfMonthlyLeaseAdjustedAnnuallyPercentage	0.03	pure
CY2014Q2	antb	Adjusted Triple Net Expense Of Lease Payments AdjustedTripleNetExpenseOfLeasePayments	34381	USD
CY2014Q2	us-gaap	Area Of Land AreaOfLand	27000	sqft
CY2014Q2	us-gaap	Security Deposit SecurityDeposit	750000	USD
CY2014Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	8075	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	-4162212	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1081792	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1864226	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	2922938	USD
CY2014	antb	Fair Value Of Warrants For Financing And Conversion FairValueOfWarrantsForFinancingAndConversion	6476606	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	690187	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	5169743	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3483408	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4287886	USD
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	4964879	USD
CY2014	antb	Stock Issued During Period Value Related Party StockIssuedDuringPeriodValueRelatedParty	275000	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2014	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	404587	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	298418	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-9730454	USD
CY2014	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2263804	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2693836	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3356000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	416337	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2658	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3432	USD
	us-gaap	Depreciation Depreciation	0	USD
	us-gaap	Depreciation Depreciation	91021	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	495120	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1864226	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2703000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	298418	USD
	antb	Warrant Expense WarrantExpense	76064	USD
	antb	Warrant Expense WarrantExpense	84558	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	24331	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	91598	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-197175	USD
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-18948	USD
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	0	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	457350	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	380727	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	590838	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-529394	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	365485	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1500	USD
	antb	Deferred Lease Liability DeferredLeaseLiability	0	USD
	antb	Deferred Lease Liability DeferredLeaseLiability	57017	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1069183	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-5115746	USD
	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	0	USD
	us-gaap	Payments For Purchase Of Other Assets1 PaymentsForPurchaseOfOtherAssets1	874960	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55000	USD
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	10212	USD
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10212	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1380015	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	270300	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	234700	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	0	USD
	antb	Repayments Of Lease Payable RepaymentsOfLeasePayable	45019	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4970453	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	9761070	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	849858	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	930106	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	6720495	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	8785945	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	5641100	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	2290184	USD
CY2013Q2	us-gaap	Cash Cash	527	USD
CY2014Q1	us-gaap	Cash Cash	5641627	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	0	USD
	antb	Warrant Value Recorded As Issuance Cost WarrantValueRecordedAsIssuanceCost	1671618	USD
	us-gaap	Nature Of Operations NatureOfOperations	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><u><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 1 Nature of Operations</font></u></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">  </font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These financial statements represent the consolidated financial statements of AntriaBio, Inc. (“AntriaBio”), formerly known as Fits My Style, Inc., and its wholly owned operating subsidiary, AntriaBio Delaware, Inc. (“Antria Delaware”). AntriaBio and Antria Delaware are collectively referred to herein as the “Company”.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On January 31, 2013, AntriaBio, a public company, acquired Antria Delaware pursuant to a share exchange agreement in which the existing stockholders of Antria Delaware exchanged all of their issued and outstanding shares of common stock of Antria Delaware for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,880,667</font> shares of common stock of AntriaBio (the “Reverse Merger”). After the consummation of the Reverse Merger, stockholders of Antria Delaware owned <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 88.2</font>% of AntriaBio’s outstanding common stock.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">As a result of the Reverse Merger, Antria Delaware became a wholly owned subsidiary of AntriaBio. For accounting purposes, the Reverse Merger was treated as a reverse acquisition with Antria Delaware as the acquirer and AntriaBio as the acquired party. As a result, the business and financial information included in this Quarterly Report on Form 10-Q is the business and financial information of Antria Delaware. The accumulated deficit of AntriaBio has been included in additional paid-in-capital<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	450055	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	AntriaBio, Inc.
	dei	Entity Central Index Key EntityCentralIndexKey	0001509261
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	ANTB
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24338219	shares
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	67500	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	0	USD
	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	450055	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	5710500	USD
	antb	Conversionofconvertiblenotespayabletocommonstock Conversionofconvertiblenotespayabletocommonstock	0	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	647342	USD
	antb	Conversionofinterestpayabletocommonstock Conversionofinterestpayabletocommonstock	0	USD
	antb	Conversionofaccountspayableandaccruedexpenserelatedparty Conversionofaccountspayableandaccruedexpenserelatedparty	275000	USD
	antb	Conversionofaccountspayableandaccruedexpenserelatedparty Conversionofaccountspayableandaccruedexpenserelatedparty	0	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	2922938	USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	0	USD
	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	433062	USD
	antb	Warrantvaluerecordedasdebtdiscount Warrantvaluerecordedasdebtdiscount	0	USD
	antb	Warrant Derivative Liability Reclassified As Equity WarrantDerivativeLiabilityReclassifiedAsEquity	0	USD
	antb	Warrant Derivative Liability Reclassified As Equity WarrantDerivativeLiabilityReclassifiedAsEquity	2217605	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	341780	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	antb	Forgiveness Of Accounts Payable And Accrued Expenses Related Party ForgivenessOfAccountsPayableAndAccruedExpensesRelatedParty	0	USD
	antb	Forgiveness Of Accounts Payable And Accrued Expenses Related Party ForgivenessOfAccountsPayableAndAccruedExpensesRelatedParty	132339	USD
	antb	Warrant Reclassifed To Equity WarrantReclassifedToEquity	2217605	USD
CY2012Q4	antb	Percentage Of Price Per Common Share On Warrant To Purchase One Share Of Common Stock PercentageOfPricePerCommonShareOnWarrantToPurchaseOneShareOfCommonStock	1.5	pure
CY2015Q1	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	5477	USD
CY2015Q1	us-gaap	Capital Lease Obligations CapitalLeaseObligations	139858	USD

Files In Submission

Name	View Source	Status
0001144204-15-031206-index-headers.html	Edgar Link	pending
0001144204-15-031206-index.html	Edgar Link	pending
0001144204-15-031206.txt	Edgar Link	pending
0001144204-15-031206-xbrl.zip	Edgar Link	pending
antb-20150331.xml	Edgar Link	completed
antb-20150331.xsd	Edgar Link	pending
antb-20150331_cal.xml	Edgar Link	unprocessable
antb-20150331_def.xml	Edgar Link	unprocessable
antb-20150331_lab.xml	Edgar Link	unprocessable
antb-20150331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v409359_10q.htm	Edgar Link	pending
v409359_ex31-1.htm	Edgar Link	pending
v409359_ex31-2.htm	Edgar Link	pending
v409359_ex32-1.htm	Edgar Link	pending
v409359_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RZLT
Rezolute, Inc. Stock $rzlt

2015 Q2 Form 10-Q Financial Statement

#000114420415031206 Filed on May 15, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT Rezolute, Inc. Stock $rzlt

2015 Q2 Form 10-Q Financial Statement

#000114420415031206 Filed on May 15, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RZLT
Rezolute, Inc. Stock $rzlt